Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Vial Size Comparison

5mg Short-term studies, single-week protocols, or infrequent dosing (once weekly for 2–3 weeks) 1mL bacteriostatic water 2 doses at 2mg concentration Lowest per-mg savings but zero waste if used within 28 days Best for pilot studies or researchers without cons

This comparison does not assign a generated winner or score.

  • 5mg
  • Short-term studies, single-week protocols, or infrequent dosing (once weekly for 2–3 weeks)
  • 1mL bacteriostatic water
  • 2 doses at 2mg concentration
  • Lowest per-mg savings but zero waste if used within 28 days
  • Best for pilot studies or researchers without consistent cold storage access
  • 10mg
  • Standard multi-week protocols with twice-weekly dosing or titration phases
  • 2mL bacteriostatic water
  • 5 doses at 2mg concentration
  • 30–40% cost reduction per mg vs 5mg vials
  • Optimal balance between economy and waste prevention for most research timelines
  • 20mg
  • Extended trials requiring >8 weeks of continuous administration
  • 4mL bacteriostatic water
  • 10 doses at 2mg concentration
  • 50–60% cost reduction per mg vs 5mg vials
  • Only economical if protocol guarantees full vial use within 28 days post-reconstitution. High waste risk otherwise
More references

Related material